Year: 2024

Organon_Logo_No_tagline

European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14

SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--$OGN #denosumabbiosimilar--Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the...

HIBIKI_PATH_ADVISORS_4371397_white_RGB

Hibiki Path Advisors Submitted Shareholder Proposals at the 53rd Annual General Meeting of Shareholders of Japan Pure Chemical Co., Ltd. Scheduled for June 25th, 2024

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (hereinafter referred to as “Hibiki” or “we”), is an asset management company based in Singapore. Its...